TH-302: Phase I data

Pooled data from a subgroup of 13 patients with non-small cell lung cancer (NSCLC) in the open-label, dose-escalation, U.S. Phase I TH-CR-401 trial and the dose-escalation Phase I part of the U.S. Pha...